A healthcare application of IoT technologies, the concept of Internet of Medical Things (IoMT) envisions a network of connected devices that sense vital data in real time.
The Internet of Medical Things (IoMT) enables machine to machine interaction and real-time intervention solutions that have the potential to radically transform healthcare as we know it, improving delivery, affordability, and reliability in the near future.
IoMT will promote personalized care and higher standards of care and living through individual data-driven treatment regimens as well as optimized devices tailored to individual physiological requirements. IoMT devices have been conceptualized in various forms of smart wearable devices, home-use medical devices, point-of-care kits, and mobile healthcare applications, and are able to communicate with medical experts in remote locations. Apart from their utility in managing regular health statuses, they have also been used for disease prevention, fitness promotion, and remote intervention in emergency situations.
Although automation in healthcare monitoring would increase operational efficiency, it may pose serious risks during implementation, such as data theft, insecure data transfers, and irregular network connections. These challenges, combined with regulatory hurdles, are expected to drive growth in IoT-based networking and data solutions. Considering the benefits and associated challenges, IoMT seems a promising solution to improve healthcare monitoring and treatment outcomes.
While IoT-based medical technology applications are still in a nascent stage, recent research in sensor, networks, cloud, mobility, and the big data domain is witnessing significant activity towards developing maximum IP coverage by companies.
Although the development of telemetric devices was first commenced in 1970 with a patent filed by both Warner–Lambert and Pacemakers Diagnostics clinic of America to disclose the telemetry, actual patent filing activities grew robustly after 1989, with the integration of biosensors into existing systems in order to capture dynamic physiological data and transmit it through wireless networks. The Internet-based medical device and remote healthcare assistance segments first flourished in the US due to the country’s major market share in conventional medical devices. Remote location-enabled technologies were rapidly adapted in the market due to their widespread clinical acceptance and healthcare policies. Due to this, major corporations opted to protect their inventions in North America, followed by Europe.
Philips, GE Healthcare, and Medtronic are the leading players in IoMT technology. Philips primarily offers cardiac monitoring, remote patient communication devices, and sensor-related products, whereas GE and Medtronic focus on cloud-based technologies in existing monitoring devices, implants, and cardiac pacemakers.
Siemens and IBM, two other players in the value chain, extend solutions in upper layers, which enable data analytics and cloud-based services to biometric data obtained from physical devices and sensors.
For more on the technologies, current intellectual property landscape, as well as future aspects of IoMT, download Aranca’s report on the Internet of Medical Things.
About the Authors
Author Bio: Dr. Yogesh Shelke, Assistant Manager, Technology Intelligence & IP Research, Aranca
Dr. Yogesh Shelke is Assistant Manager in the Intellectual Property and Technology Research practice at Aranca and manages the Healthcare, Pharma & Medical Devices sector. Being a healthcare professional and registered Indian patent agent, he has executed and overseen a number of projects across Clinical Service Delivery, Medical devices and Healthcare IP across leading global markets. He has been associated with Aranca for over 3 years where he provides technical expertise to technology and IP insights, R&D roadmaps, feasibility studies and innovation management. Yogesh has also been associated with Franks and Government Tertiary care hospitals previously. He started his professional career with medical education and pursued his interest in medical innovations during his masters at Indian Institute of Technology, Bombay. He further completed MBA studies from SJM School of Management in Indian Institute of Technology, Bombay.
Contributor Bio : Arpit Sharma, Manager, Technology Intelligence & IP Research, Aranca
Arpit Sharma is a Manager in the Intellectual Property and Technology Research practice at Aranca and manages team working on Electronics, Healthcare, & Biomedical technologies. He has over nine years of experience in intellectual property consulting industry and academics, he has supported various fortune 500 companies for IP valuation assignments, new product development, application scouting, and innovation management.
Being an Electrical engineer and masters in Biomedical Engineering from IIT- BHU, his technological interest lies in power systems, power electronics, and medical instrumentation specifically for paediatric use. He started his career with academics and has also guided students for developing control system for infant radiant warmer and foetal heart rate monitor.